Certara, Inc. (CERT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 12:48PM EDT. Market open.
| Previous close | 17.60 |
| Open | 17.63 |
| Bid | 17.28 x 100 |
| Ask | 17.39 x 100 |
| Day's range | 17.33 - 17.64 |
| 52-week range | 11.81 - 23.54 |
| Volume | |
| Avg. volume | 522,661 |
| Market cap | 2.776B |
| Beta (5Y monthly) | 1.63 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
What Makes Certara (CERT) an Attractive Bet?
The London Company, an investment management company, released “The London Company Small Cap Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here. In the quarter, the fund gained 8.3% (8.2%, net) compared to a 5.2% increase in the Russell 2000 Index. Stock selection led the portfolio to outperform in […]
- GuruFocus.com
Insider Sell: President of Drug Dev Solutions at Certara Inc (CERT) Sells Shares
Certara Inc (NASDAQ:CERT), a global leader in biosimulation, provides software, consulting, and technology-enabled services to support drug discovery, development, and regulatory science.
- Simply Wall St.
Certara, Inc.'s (NASDAQ:CERT) Intrinsic Value Is Potentially 66% Above Its Share Price
Key Insights The projected fair value for Certara is US$29.68 based on 2 Stage Free Cash Flow to Equity Current share...
© 2024 Yahoo. All rights reserved.